Modulators of actin-myosin dissociation: basis for muscle type functional differences during fatigue by Karatzaferi, Christina et al.
Kent Academic Repository
Full text document (pdf)
Copyright & reuse
Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all
content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions 
for further reuse of content should be sought from the publisher, author or other copyright holder. 
Versions of research
The version in the Kent Academic Repository may differ from the final published version. 
Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the 
published version of record.
Enquiries
For any further enquiries regarding the licence status of this document, please contact: 
researchsupport@kent.ac.uk
If you believe this document infringes copyright then please contact the KAR admin team with the take-down 
information provided at http://kar.kent.ac.uk/contact.html
Citation for published version
Karatzaferi, Christina and Adamek, Nancy and Geeves, Michael A.  (2017) Modulators of actin-myosin
dissociation: basis for muscle type functional differences during fatigue.   American Journal of
Physiology - Cell Physiology, 313  (6).   C644-C654.  ISSN 0363-6143.
DOI
https://doi.org/10.1152/ajpcell.00023.2017





Modulators of actin-myosin dissociation: basis for muscle type 1 
functional differences during fatigue 2 
 100 characters incl. spaces 3 
Authors: Christina Karatzaferi 
1,2
, Nancy Adamek 
 3




Muscle Physiology and Mechanics Group, DPESS, University of Thessaly, Karyes, 5 
Trikala, 42100, Greece 6 
2 
Experimental Myology and Integrative Physiology Cluster, FSHS, University of St 7 
Mark and St John, UK8 
3
School of Biosciences, University of Kent, Canterbury, CT2 7NH Kent, UK 9 
10 
Running head: Muscle type actomyosin dissociation differences in fatigue 11 
58 characters incl. spaces 12 
Address for correspondence: M.A. Geeves, School of Biological Sciences, University 13 
of Kent, Canterbury, CT2 7NH Kent, UK, M.A.Geeves@kent.ac.uk 14 
Author contributions: CK & MAG conceived the study, MAG & CK designed the study, 15 
NA & CK collected data, NA created figures and tables, all co-wrote and edited the 16 
original manuscript, CK and MAG revised the manuscript.  17 
18 
Articles in PresS. Am J Physiol Cell Physiol (September 20, 2017). doi:10.1152/ajpcell.00023.2017 
2 
 
Abstract   19 
The muscle types present with variable fatigue tolerance, in part due to the myosin  20 
ŝƐŽĨŽƌŵĞǆƉƌĞƐƐĞĚ ?,ŽǁĞǀĞƌ ?ƚŚĞĐƌŝƚŝĐĂůƐƚĞƉƐƚŚĂƚĚĞĨŝŶĞ ‘ĨĂƚŝŐĂďŝůŝƚǇ ?in vivo of fast 21 
vs slow myosin isoforms, at the molecular level, are not yet fully understood. We 22 
examined the modulation of the ATP-induced myosin sub-fragment 1 (S1) 23 
dissociation  from pyrene-actin by inorganic phosphate (Pi), pH and temperature 24 
using a specially modified stopped-flow system that allowed fast kinetics 25 
measurements at physiological temperature. We contrasted the properties of rabbit 26 
psoas (fast) and bovine masseter (slow) myosins (obtained from samples collected 27 
from New Zealand rabbits and from a licensed abattoir, respectively, according to 28 
institutional and national ethics permits). To identify ATP cycling biochemical 29 
intermediates, we assessed ATP binding to a pre-equilibrated mixture of actomyosin 30 
and variable [ADP],  pH (pH 7 vs pH 6.2) and Pi (zero, 15 or 30 added mM Pi) in a 31 
range of temperatures (5 to 45
o
C). Temperature and pH variations had little, if any, 32 
effect on the ADP dissociation constant (KADP) for fast S1 but for slow S1 KADP was 33 
weakened with increasing temperature or low pH. In the absence of ADP, the 34 
dissociation constant for phosphate (KPi) was weakened with increasing temperature 35 
for fast S1. In the presence of ADP, myosin type differences were revealed at the 36 
apparent phosphate affinity, depending on pH and temperature. Overall, the newly 37 
revealed kinetic differences between myosin types could help explain the in vivo 38 
observed muscle type functional differences at rest and during fatigue. 39 
246 words  40 
 41 
Keywords: myosin kinetics, cross-bridge cycle, temperature, muscle fatigue 42 




Myosin II exists in multiple isoforms (49) with slow muscles expressing the type 1  45 
(MyHC- ?ĂůƐŽŬŶŽǁŶĂƐɴŵǇŽƐŝŶ ?ĂŶĚfast muscles expressing one or more of the 46 
type 2 myosins (MyHC-2a, 2b, or 2x).  Contraction depends directly on the 47 
interaction of myosin II multi-ŚĞĂĚĞĚĨŝůĂŵĞŶƚƐ ?ǁŝƚŚĨŝůĂŵĞŶƚŽƵƐ ‘ƚƌĂĐŬƐ ?ŽĨĂĐƚŝŶ ?48 
arranged within the ƐĂƌĐŽŵĞƌĞƐ ?ƚŚĞ ‘ĨƵŶĐƚŝŽŶĂůƵŶŝƚƐ ?ŽĨŵƵƐĐůĞ(28, 47). Eventually, 49 
whole muscle force output depends on the number of myosin cross-bridges 50 
ŝŶƚĞƌĂĐƚŝŶŐ ‘ƐƚƌŽŶŐůǇ ?Žƌ ‘ǁĞĂŬůǇ ?ǁŝƚŚĂĐƚŝŶ ?ǁŚŝůĞƚŚĞǀĞůŽĐŝƚǇŽĨĐŽŶƚƌĂĐƚŝŽŶ51 
depends on the rate at which  myosin detaches from actin at the end of the working 52 
stroke (11).  53 
The study of kinetics of the actomyosin (A.M) interaction cycle identifies clear 54 
intermediate steps  (for a review see (5)).  Such studies have revealed that slow 55 
skeletal myosin heavy chain isoforms (MyHC 1) have distinct properties from fast 56 
isoforms (MyHC 2s), e.g. regarding ATPase activity and the rate and equilibrium 57 
constants of the various biochemical steps, which are expected to dictate their 58 
different mechanical properties.  Thus, efficiency of actin-induced ADP displacement 59 
from myosin (the ratio of the ADP dissociation constant for A.M (KADP) over the ADP 60 
dissociation constant for myosin (KD)), and strain sensitivity (dependence on external 61 
mechanical load) can differ substantially between fast and slow myosins (5, 22) , 62 
with slow myosins binding ADP tightly and releasing it at a slower rate than fast 63 
myosins. Consequently, ADP release is considered the rate limiting step for the 64 
maximum contraction velocity of slow muscles (29, 44), at least at the temperatures 65 
where fibers or myosin solutions are usually studied (10 to 22 °C). 66 
The coupling of biochemical steps with mechanical events has, however, not been 67 
fully elucidated (22) ǁŚŝůĞƚŚĞ ‘ůĂǁƐ ?ŐŽǀĞƌŶŝŶŐŚŽǁĞŶƐembles of myosins  integrate 68 
within the organized sarcomere (18, 19, 40) are not yet fully defined; this can be 69 
attributed partly to lack of physiologically relevant experimental evidence at the 70 
molecular level. This is especially true on the question of muscle fatigue, a complex 71 
multifaceted phenomenon.  72 
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At the organismal level, fatigue has a large heterogeneity of research outcomes (6) 73 
depending on the type, duration and intensity of muscular activity employed (8, 10), 74 
the muscle composition studied (24) and health status (30), etc. In terms of 75 
intramuscular biochemical changes, the degree of acidosis observed depends on the 76 
rate and extent to which anaerobic glycolysis is relied upon; which in turn is 77 
dependent on the fiber type and type of activity (i.e. more iŶ ‘ƐƵƉƌĂŵĂǆŝŵĂů ? ?ƐƉƌint 78 
type work, more in ischemia) as well as the presence and activity of lactate and 79 
proton transporters (see e.g. (32)). Brief very intense voluntary exercise has been 80 
shown, in mixed muscle, to lower pH from 7.1 to 6.4 (7, 8, 27, 31, 48) and to disturb 81 
the ATP and phosphocreatine levels, notably in fast, type II, fibers to near depletion 82 
(34, 35). Based on NMR data, ADP levels are calculated to rise to 200 µM (21) as, in 83 
healthy muscle, they are well buffered by the adenylate kinase and AMP deaminase 84 
reactions (26). Still, small variations in [ADP] can significantly affect the sarcoplasmic 85 
ƌĞƚŝĐƵůƵŵ ?ƐĨƵŶĐƚŝŽŶ(39), and may help in maintaining tension economy (37). The 86 
drop in pH affects not only calcium sensitivity (20) but also the effect of accumulated 87 
Pi, which can reach 20-30mM in exercising muscle (2, 38), with its di-protonated 88 
form considered to inhibit force (for a review see (2)). At the myofibrillar level, 89 
changes in muscle mechanics during fatigue could be related to either reduction of 90 
energy substrates (e.g. causing localized ATP minima (34, 35)) and /or accumulation 91 
of ATP hydrolysis by-products (e.g. (14, 33, 37, 45, 53) ). This is because the 92 
interaction of myosin with actin (actomyosin) is a multi-substrate and multistep 93 
reaction i.e. not only fueled by ATP hydrolysis but also modulated by ATP hydrolysis 94 
by-products (ADP, Pi, H
+
) and other prevailing intracellular conditions (12). Thus, for 95 
the purposes of this work, fatigue is considered in the context of factors influencing 96 
the actomyosin cycle in a way to cause slowing of the cycle and/or weaker 97 
actomyosin interactions. 98 
Overall, investigations ranging from whole body exercise (8, 30), to intact small 99 
muscles or fibers (59)  to skinned fibers, (13, 14, 17, 33, 37, 46) or myofibrils (53), 100 
and few isolated molecule approaches [e.g. (16)] have provided strong evidence that  101 
the accumulation of inorganic phosphate (Pi) and of hydrogen ions can contribute to, 102 
if not cause, peripheral muscle fatigue. Still, their exact impact, especially at 103 
5 
 
physiological in vivo conditions, has attracted much debate (e.g. (58)). This is further 104 
complicated by muscle type differences (fast vs slow) in energetics, myosin ATPase, 105 
and mechanical performance (9, 49, 50) , which can be linked to a great degree to 106 
inherent properties of the myosin II isoform expressed. 107 
Our understanding of fatigue effects is further complicated by muscle type 108 
differences (fast vs slow) in energetics, myosin ATPase, and mechanical performance 109 
(9, 49, 50) , which can be linked to a great degree to inherent properties of the 110 
myosin II isoform expressed. The steps that control the detachment of the myosin 111 
cross-bridge at the end of the working stroke from actin are rapid and are thought to 112 
limit the shortening velocity, a key parameter of muscle function. Temperature 113 
predictions from kinetic studies of actomyosin in solution (44), suggest that the rate 114 
of ADP release may limit unloaded velocity for both fast and slow myosin isoforms. It 115 
can be hypothesized that such an ADP effect could be aggravated by the presence of 116 
hydrogen ions and inorganic phosphate, as in fatigue, but it is not known if this is the 117 
case and what would be the role of the myosin type. 118 
Moreover, a parameter not often considered is temperature. In vivo mammalian 119 
muscle temperature ranges from 32 to > 40 °C, while in severe fatigue, pH drops and 120 
inorganic phosphate (Pi) accumulates (23) concomitantly. A number of in vitro fiber 121 
studies at higher temperatures, have challenged long held views about the individual 122 
ƌŽůĞŽĨƚŚĞŬĞǇ ‘ĨĂƚŝŐƵĞ ?ŵĞƚĂďŽůŝƚĞƐŽŶŵĞĐŚĂŶŝĐƐ ? ?Ğ ?Ő ?ů ƐƐŽĨĂŶĞĨĨĞĐƚŽĨƉ,(36, 123 
45, 59)) or Pi on force, (13, 14, 17, 33)).  Thus, it appears that employing  124 
temperature modulations in the in vitro experimentation is necessary to tease out 125 
physiological synergies [e.g. a synergism of myosin light chain phosphorylation with 126 
low pH and high [Pi] became evident only at a high temperature (36) ], if one wants 127 
to realistically link muscle function in vivo to actomyosin interaction molecular 128 
events studied in vitro. This necessitates molecular experimentation that mimics 129 
physiology to the degree possible. 130 
Therefore the purpose of this research was to study the fast kinetics of ATP-induced 131 
dissociation of A.M. with and without ADP using the stopped flow.  We examined the 132 
ŝŶƚĞƌƉůĂǇŽĨ ‘ĨĂƚŝŐƵĞ ?ĨĂĐƚŽƌƐ ?Ğ ?Ő ?ůŽǁƉ,ĂŶĚŚŝŐŚŝŶŽƌŐĂ ŝĐƉŚŽƐƉŚĂƚĞ ?Wŝ ? ?ǁŝƚŚ133 
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myosin type, on ATP-induced dissociation of A.M.  Taking advantage of recent 134 
methodological advancements we studied, for the first time, the ATP-induced 135 
dissociation of fast and slow S1 from actin in temperatures ranging from 5 to 45 
o
C to 136 
reveal critical myosin type and/or temperature dependencies of these processes. 137 
 138 
Glossary & abbreviations 139 
A.M: actomyosin complex  140 
S1: myosin subfragment 1 141 
actin.S1: actin bound with S1 142 
K1 : equilibrium constant for the formation of the complex of AM with ATP (denoted 143 
as A.M.T),  144 
k+2: rate constant of isomerization of A.M.T to A~M.T which is followed by actin 145 
dissociation 146 
kobs: observed rate constant of ATP induced dissociation of myosin from actin   147 
KADP: dissociation constant for ADP  148 
KPi: dissociation constant for phosphate  149 
KADP+Pi: dissociation constant for ADP in the presence of phosphate 150 
MyHC: myosin heavy chain 151 
 152 
Materials and methods 153 
Ethics Statement 154 
Muscle tissue was obtained post-mortem from animals treated as recommended by 155 
national and local guidelines (UK Animals (Scientific Procedures) Act, 1986).  Fast 156 
skeletal muscle came from the psoas muscle of New Zealand rabbits and slow 157 
skeletal muscle from bovine masseter.  158 
Protein preparation 159 
Myosin was prepared from the rabbit psoas (for fast MyHC-II) and the bovine 160 
masseter muscle (for slow MyHC-I) according to Margossian and Lowey (41) , and 161 
was subsequently digested to subfragment 1 (S1) with chymotrypsin as described by 162 
Weeds & Taylor (57) which removes the regulatory light chain region.  These two 163 
muscle types yield essentially pure MyHC isoform (e.g. (1, 25) for rabbit psoas  164 
(isoform 2X) and (55) for bovine masseter (isoform 1) a result confirmed in routine 165 
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SDS-PAGE by us and others  and by the expected value of KADP which is characteristic 166 
of a pure MyHC isoform (as indicated e.g. in (4)). 167 
Actin was prepared from rabbit muscle as described by Spudich & Watt (52)  and 168 
labelled with pyrene iodoacetamide to give pyrene-labelled actin as described by 169 
Criddle et al (15). Protein stocks of S1 and of pyrene-labelled actin were stored at 4
o
C 170 
and were used for up to 2 weeks.  In the text herein reference to actin implies 171 
pyrene-labelled actin. 172 
 173 
Experimental buffers 174 
The main buffer contained 20 mM cacodylate (adjusted at pH 7.0 or pH 6.2), 100 175 
mM KCl, 5 mM MgCl2 and 1 mM NaN3; when phosphate was present in the buffer 176 
the ionic strength was adjusted accordingly to a final ionic strength of 170 mM. 177 
Concentrations (whether of proteins or buffer constituents) given in the text and 178 
figure legends refer to the concentration after mixing 1:1 in the stopped flow (unless 179 
stated otherwise). 180 
 181 
Experimental equipment, procedures and analysis 182 
Stopped-flow experiments were performed essentially as described previously (4)  183 
using a HiTech Scientific SF-61DX2 stopped flow system and 4-5 transients were 184 
acquired for each ATP transients (Kinetic Studio suite).  The dead time of the 185 
equipment was 0.002 s.  A wide temperature range (5  ? 45 oC) for measurements 186 
was available because of a new adaptation of the standard stopped flow machine 187 
(see (56)). Briefly, the drive syringes were held at room temperature (20 °C) while 188 
loading lines leading into the mixing chamber, the mixing and observation chamber 189 
were all thermostated at the temperature of the measurement.  Essentially the 190 
samples were only exposed to the temperature of the measurement for a few 191 
seconds, thus allowing measurements of proteins under conditions where they are 192 
not usually stable for long.   193 
 194 
The ATP induced dissociation rate of actin.S1, was measured in the stopped-flow by 195 
mixing a fixed concentration of pyr.actin.S1 complex (end concentration 0.25 µM) 196 
with excess ATP and monitoring fluorescence transients from the pyrene-labeled 197 
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actin (excitation at 365 nm, emission through a KV389 nm cut-off filter (Schott, 198 
Mainz, Germany)). Details of the kinetic analysis are given under data fitting. 199 
 200 
In a similar process, ADP dissociation constant (KADP), which defines ADP affinity for 201 
actin.S1, was measured by adding to the mixture ADP as a competitive inhibitor of 202 
ATP binding. In this case it is convenient to add the ADP to the ATP solution, i.e. 0.5 203 
µM pyr.actin.S1 was mixed with 25 µM ATP with various concentrations of ADP 204 
present with the ATP (from 0 to 1200 µM). This approach assumes that ADP is in 205 
rapid equilibrium with the actin.S1 complex on the time scale of the ATP induced 206 
dissociation reaction.  This was ensured by using the low (25 µM) concentration of 207 
ATP.  That this assumption holds was tested by repeating the measurement with 208 
ADP pre-incubated with actin.S1 and then mixing with ATP.  The observed rate 209 
constants were identical in each case.  Details of the data analysis are given below 210 
(see Scheme 1 on the competitive inhibitor approach, and equation 4). 211 
 212 
Phosphate dissociation constant (KPi) was measured exactly as for the ADP 213 
dissociation constant except that the high concentrations of Pi used meant it was 214 
more convenient to have Pi present in the buffer in both syringes of the stopped-215 
flow. Details of the data analysis are given below (see Scheme 1 on the competitive 216 
inhibitor approach, and equations 5 and 6). 217 
 218 
ADP dissociation constant in the presence of phosphate (KADP+Pi) was also measured 219 
using the same approach as for KADP but using buffers containing fixed amounts of 220 
inorganic phosphate, 30 mM in the case of psoas S1 and 15 mM with masseter S1. 221 
The different affinities of Pi for the two types of S1 required a different 222 
concentration of Pi.     Preliminary data indicated that Pi binding to psoas S1 was > 10 223 
mM and weaker than to masseter S1, by approximately a factor of 2.  Since the limits 224 
of ionic strength precluded using saturation amounts of Pi we used a Pi 225 
concentration close to the range of KPi  values. 226 
 227 
Experiments were performed at two pH levels, 7 and 6.2 and in a range of 228 
temperatures. Care was taken to reverse the order of experiments to avoid the 229 
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ƉŽƐƐŝďŝůŝƚǇŽĨĂƚŝŵĞĂŶĚ ‘ŽƌĚĞƌ ?ĞĨĨĞĐƚĞŝƚŚĞƌǁŝƚŚƌĞƐƉĞĐƚƐƚŽƉ,ŽƌƚĞŵƉĞƌĂƚƵƌĞ ? 230 
 231 
Data Fitting and Interpretation Approach 232 
In the present study we focused our attention on the ATP induced dissociation of 233 
actin.S1. This is the step that controls the detachment of the actomyosin cross-234 
bridge at the end of the working stroke.    235 
 236 
 237 
Scheme 1. Model of ATP-induced dissociation of actin.S1 based on Millar and Geeves 238 
(42) .  239 
 240 
In Scheme 1, T = ATP; A = actin; M = myosin; I is an inhibitor, competitive with ATP 241 
for the nucleotide binding site. K1 defines the equilibrium constant for the formation 242 
of the A.M.T collision complex, which is followed by an almost irreversible 243 
isomerization of the complex to the ternary complex A~M.T with the rate constant of 244 
k+2. This is rapidly followed by dissociation of actin from the ternary complex. KI is 245 
defined as a dissociation constant k-I/k+I.  In the experiments presented here the 246 
inhibitor was either ADP or inorganic phosphate (Pi). 247 
 248 
The reaction described in Scheme 1 was monitored through pyrene fluorescence 249 
changes which monitor the ATP induced dissociation of actin from the complex 250 
(fluorescence increases by up to 70 %.), specifically associated with step 2 of Scheme 251 
1, (see in Results, Fig. 1A). Four to five transients were collected for each ATP 252 
concentration used then averaged before further analysis.  253 
 254 
The averaged transients were fitted with single (eqn1) or, if needed, a double 255 
exponential equation (eqn2):  256 
 257 
f
 ' FeFF tkt obs )(     eqn 1 258 
or  259 
f




Where Ft is the observed fluorescence at time t, FA? is the fluorescence at the end of 262 
ƚŚĞƚƌĂŶƐŝĞŶƚ ?ƚA?A䰃?ĂŶĚȴ&ŝƐƚŚĞƚŽƚĂůĐŚĂŶŐĞŽĨĨůƵŽƌĞƐĐĞŶŽďƐĞƌǀĞĚ ?dŚĞ263 
observed rate constant (kobs) reflects the ATP induced dissociation rate of actin.S1 264 
and is linearly dependent on [ATP], at the ATP concentrations used here.  A plot of 265 
[ATP] vs kobs was used to derive the  values of K1 and k+2 (using Origin v 6.0), as 266 
defined in scheme 1 and eqn 3. 267 
  268 
kobs = K1k+2[ATP] eqn 3 269 
 270 
 271 
The presence of a competitive inhibitor to ATP binding (that does not induce actin.S1 272 
dissociation) would appear to slow the rate of actin.S1 dissociation.  If inhibitor 273 
binding is in rapid equilibrium with actin.S1, within the timescale of data acquisition, 274 
compared to the rate of ATP-induced dissociation of actin.S1 (i.e.  k+AD +[ADP]k-AD >> 275 
K1k+2[ATP]) , then   276 
 277 
kobs = K1k+2[ATP]/(1 + ([I]/KI))   eqn 4  278 
 279 
Then, plotting kobs as a function of [I] will allow the KI (in scheme 1) to be defined. 280 
This approach was used to define the value of KI for ADP ( KADP)  and Pi ( KPi).  281 
 282 
If both ADP and Pi are present in the same measurement, two scenarios are possible.  283 
If both compete for the same binding site then the effect of the two inhibitors is 284 
additive and the effect on kobs can be predicted from the values of KADP and KPi 285 
measured independently. 286 
 287 
 kobs = K1k+2[ATP]/(1 + ([ADP]/KADP) +  ([Pi]/KPi)) eqn 5 288 
 289 
where the measured KI  with variation of [ADP] and  fixed [Pi]    is  KI =    1/KADP  + 290 
[Pi]/KPi 291 
 292 
If both however bind into the ATP pocket at the same time to create the complex 293 
A.M.ADP.Pi then the above relationship will not hold and Pi will alter the affinity of 294 




The apparent affinity of ADP for actin.S1 (KADP+Pi) was measured for several 297 
concentrations of Pi and then the dissociation constant of Pi calculated according to 298 
the following relationship and compared with the value of KPI. 299 
KPi app = [Pi]/( KADP+Pi/KADP  ? 1)      eqn 6 300 
 301 
 302 
ADP release rate constant.  Two types of myosins were studied which are known to 303 
differ in their dissociation constant for nucleotides (5, 51).  The rate constant for the 304 
release of ADP (k-ADP) is relatively slow for masseter S1 and can easily be measured in 305 
an ADP displacement experiment.  This step is very fast for a fast muscle isoform and 306 
too fast to measure by current equipment.   Briefly, actin.
Mass
S1 saturated with 75 307 
µM of ADP (A.M.D complex) was mixed with a large excess of ATP (8 mM) in the 308 
stopped-flow. Then the kobs values, fitted to a single exponential equation (eqn 1) 309 
defined the rate constant by which ADP is released by the ternary A.M.D complex (k-310 
AD).   311 
 312 
The data presented in the figures are the values for the  individual experiment 313 
displayed, while the data values presented in the table 1 are averaged values for n = 314 
independent day measurements. 315 
 316 
The temperature dependence of the above studied biochemical steps K1k+2,  KADP, KPi 317 
and KADP+Pi data were plotted as the natural logarithm  of the measured parameter  318 
against the reciprocal of temperature in degrees Kelvin (1/T 
o
K) and fitted with linear 319 
regression using the Arrhenius (rate constants) or Van ?ƚ Hoff (equilibrium constants)  320 
equations   321 
 322 
ln K1k+2 =ln (A)- Ea/RT   eqn 7 323 
 324 
>Ŷ<ĞƋA?ȴ^ ? ?Z- ȴ, ? ?Zd eqn 8 325 
 326 
where Ea stands for activation energy, R is the gas constant, A is a pre-exponential 327 




Results & Discussion 330 
ATP induced dissociation rate of actin.S1. When actin.
Pso
S1  and actin.
Mass
S1  were 331 
mixed with ATP,  as shown in Figure 1 A and B, the observed stopped-flow transients 332 
were described by a single exponential for both myosin isoforms (Fig 1A and 1B).  333 
Keeping a fixed ATP concentration and increasing the temperature allows the best 334 
estimate of the temperature dependence of the reaction since it minimizes variation 335 
in ATP concentration between experiments.  Increasing the temperature from 5-43 336 
°C reduced the total fluorescence signal by ~ 40%  due to collisional quenching but 337 
the signal change remained relatively constant with an approximately 2-fold increase 338 
in fluorescence observed in all transients. The transients were therefore normalized 339 
to illustrate the change in the kobs values.   For psoas (Fig 1 A) and masseter (Fig 1 B) 340 
temperature increased the kobs value ~3 fold in both cases over the range of 341 
measurements from 3 to 43 °C.  The figure shows illustrative examples of one set of 342 
transients.     343 
Lowering the pH to 6.2 slightly increased the kobs values for both isoforms by about 344 
20-25 % (and hence the second order rate constant K1k+2, see Table 1).    Increasing 345 
temperature resulted in an average increase of 3 fold over the temperature range of 346 
5-35 °C. The amplitudes of the transients at pH 6.2 were again relatively stable and 347 
similar to pH 7 for 
Pso
S1 at 43 %. For 
Mass
S1 the amplitudes were also stable in pH 6.2 348 
but showed an overall increase in fluorescence from 40 to 50% of total fluorescence 349 
signal. 350 
Effect of temperature: The temperature dependence of the dissociation rate 351 
constant was examined at pH 7 and then repeated at pH 6.2 (Fig 1C and 1D).   Each 352 
measurement was repeated 3 times and the average values collated in Table 2. The 353 
Arrhenius plots of the temperature dependence measurements at pH 7 and 6.2 gave 354 
well defined straight lines over the temperature range (5  ? 43 oC). In the absence of 355 
phosphate, for psoas the activation energy (Ea) values were very similar at pH 7.0 356 
and 6.2 as shown in Figure 1 C, 28.3 ± 0.8 and 29.3 ± 0.8 kJ/mol respectively.  For 357 
masseter, Ea values were on average lower than the ones for fast, being for pH 7.0 358 
and 6.2, 25.7 ± 1.4 and 23.8 ± 1.1 kJ/mol respectively (Figure 1D). 359 
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Effect of Pi and pH: When the ATP-induced dissociation measurements were 360 
repeated in the presence of high phosphate concentrations, of the order that might 361 
be expected in fatigue, the observed rate constants for the dissociation reaction 362 
were 2-fold slower for 
Mass
S1 and 2- to 3-fold slower for 
Pso
S1 at both pH levels 363 
compared to the data in the absence of phosphate.  This is consistent with Pi acting 364 
as a competitive inhibitor with a Ki of 10  ? 20 mM. It should be noted that while 30 365 
mM Pi was used for 
Pso
S1, 15 mM Pi was used for 
Mass
S1 experiments.  366 
The transients of both isoforms had bi-phasic tendencies at the low temperatures (5-367 
10 °C) at both pHs, but were single exponential at all other temperatures. The origin 368 
of this additional slow phase, which had a very small amplitude (1-3 %), is not 369 
known, but possible contamination by ADP was eliminated by control measurements 370 
in the presence of apyrase which converts any ADP present, which does not bind to 371 
S1, to AMP.  372 
The amplitudes of the dissociation reaction were 50 % smaller/reduced in the 373 




S1, indicating some loss of affinity of 374 
S1 for actin in the presence of Pi.  However, for psoas the amplitudes increased with 375 
temperature from 25 to 30 % at pH 7.0 and even more dramatically from 12 to 20 % 376 
at pH 6.2. This behavior was not observed with 
Mass
S1 masseter.  377 
Combined effect of temperature, pH and phosphate: the temperature dependence of 378 
the dissociation rate constant in the presence of phosphate is shown in Figure 2 and 379 
the activation energies determined for psoas (38 ± 1 kJ/mol) and masseter (30 ± 1 380 
kJ/mol) were greater than in the absence of Pi, irrespective of the pH used. Thus 381 
phosphate increased the activation energy of 
Pso
S1 at both pH values by about 10 382 
kJ/mol, which is a larger increase than observed with masseter, where the increase 383 
was only about 5 kJ/mol in the presence of phosphate. 384 
Rate constant of ADP release (k-ADP) was evaluated by an ADP displacement 385 
experiment, mixing actin.
Mass
S1 saturated with ADP with an excess of ATP. This 386 
measurement was not possible for 
Psoas




Displacement of ADP from actin.
Mass
S1 by a large excess of ATP was biphasic. The 389 
transients were well-defined with stable amplitudes of 24 and 6 % for the fast and 390 
slow phase, respectively (as shown in Figure 3 A).  These amplitudes were similar 391 
under all conditions explored. The fast phase defines the rate constant at which ADP 392 
is released and is thought to limit the velocity of shortening of a masseter muscle (4).  393 
The slower phase is an off pathway event and will not be considered further here. 394 
The kobs of the ADP release was 85 s
-1
 at 20 °C (pH 7.0) and compares well to 395 
published results of 94 s
-1
 by Bloemink et al (4). 396 
 397 
The reaction was measured over the temperature range of 5 - 30 °C at pH 6.2 and 398 
7.0, and in the presence of 15 mM Pi.   The kobs values are summarized in the 399 
Arrhenius plot in Fig 3B. The kobs values increased from 16.2 at 5 °C to 273 s
-1
 at 30 °C 400 
with similar values at pH 7.0 and pH 6.2 throughout the temperature range used.  401 
Above 30 °C the reaction was too fast to measure reliably.   Thus the activation 402 
energy was large with similar values at both pH levels studied. 403 
 The addition of 15 mM Pi had little effect at pH 7.0. At pH 6.2 however we saw a 30-404 
50 % increase in kobs in the presence of phosphate and a small change in the 405 
activation energy.   406 
 407 
ADP dissociation constant (KADP)  408 
The ADP dissociation constant (KADP) for pyr.actin.S1 was measured by the 409 
competitive inhibitor approach as described in the Methods.  410 
ADP included in the ATP solution competes with ATP for binding to the pyr.actin.S1 411 
and slows the kobs value as shown in Fig 4. The ADP dissociation constant was 168 412 
µM for  
Pso
S1 and 31 µM for 
Mass
S1 at 20 °C and pH 7.0, as reported previously (22).  413 
This large difference in the affinity of actin.S1 for ADP is a major characteristic of a 414 
fast vs a slow myosin isoform.  As reported previously the ADP affinity for psoas  415 
actin.S1 was relatively unaffected by temperature (about 200 ±30 µM between 10 416 
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and 30 °C) while for masseter the effect was much greater, with the affinity 417 
becoming weaker by ~6-fold from 9.6 µM at 10 °C to 62.4 at 30 °C, at pH 7.0. 418 
Effect of pH: A change in pH did not affect the ADP affinity for psoas (Table 1) over 419 
the temperature range studied (also Figure 4C). Lowering the pH to 6.2 with 
Mass
S1 420 
resulted in 2-fold weaker KADP values than at pH 7.0 (from 10 to 22 µM at 10 °C). 421 
However, this effect of pH was not as pronounced at higher temperatures (only 422 
weakening by 1.5 fold at 30 °C, see Table 1).  423 
 424 
Phosphate dissociation constant (KPi) 425 
The dissociation constant of Pi for actin.S1 (KPi) was measured but the range of Pi 426 
concentrations accessible was restricted by the need to maintain a constant ionic 427 
strength.  As Pi was increased the concentration of KCl in the buffer was decreased 428 
and the maximum phosphate concentration used was 30 mM.  Figure 6 shows the 429 
plots of kobs as a function of phosphate concentration for the two myosin isoforms.  430 
These show the expected inhibition as [Pi ] is increased with an average KPi value of 431 
15 mM at 10 °C decreasing to 41 mM at 40 °C for actin.
Pso
S1 at pH 7.0. Decreasing 432 
the pH to 6.2 did not significantly affect the KPi values for 
Pso
S1 (11 mM at 10 °C, 433 
decreasing to 32 mM at 40 °C, see also Table 1).   434 
Repeating the measurements with 
Mass
S1 gave a KPi of 22 mM at 10 °C, weakened to 435 
35 mM at 20 °C (pH 7.0). Lowering the pH to 6.2 resulted in an average KPi value of 436 
17 mM at 10 °C, weakening to 28 mM at 40 °C. Thus a differential response of slow 437 
myosin to Pi was observed with temperature, with the slow myosin while starting off 438 
less sensitive to Pi at 10°C becoming more sensitive to Pi at 40°C. 439 
 440 
ADP dissociation constant in the presence of phosphate (KADP+Pi) was evaluated as 441 
for the ADP dissociation constant but using fixed amounts of inorganic phosphate 442 
(30 mM in the case of 
Pso
S1 and 15 mM with 
Mass
S1). The presence of 30 mM Pi 443 
weakened the ADP dissociation constant (KADP+Pi) for actin.
Pso
S1 3-4-fold (from about 444 
170 µM to 890 µM at 20 °C (pH 7.0)) as shown in Figure 5A and Table 1.  Repeating 445 
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the measurement at different temperatures showed the apparent KADP weakening  446 
from around 500 µM at 10-20 °C to 942 µM at 30 °C (Fig 5C and Table 1).   For 447 
masseter the effects of Pi were less marked, with the KADP weakening only 1-2-fold 448 
across the temperature range at pH 7.0. Overall, it appears that phosphate competes 449 
with ADP binding to fast A.M, but has little effect on ADP binding in slow A.M. The 450 
formation of an A.M.ADP.Pi complex (see Data Fitting and Interpretation Approach) 451 
is not supported under our experimental conditions. 452 
Lowering the pH to 6.2 resulted in a smaller effect of phosphate on the ADP 453 
dissociation constant for actin. 
Pso
S1, changing only 2-fold from 228 to 514 µM at 20 454 
°C (compared to the 3 to 4-fold change seen at pH 7.0). This reduced effect of 455 
phosphate was seen across the temperature range used. In actin.
 Mass
S1, 15 mM Pi 456 
weakened the ADP affinity 2-fold from 47 to 94 µM at 20 °C, and a similar 2-fold 457 
weakening of the KADP in phosphate (KADP+Pi ) was seen at the other temperatures 458 
used at pH 6.2. 459 
Apparent phosphate dissociation constant (KPi app) 460 
The apparent dissociation constant of phosphate for acto-myosinS1 (KPi app) in the 461 
presence of ADP was calculated from the ADP dissociation constants measured in 462 
the absence (KADP) and presence of phosphate (KADP+Pi) as detailed in the methods. At 463 
pH 7.0 and low temperature the KPi app of actin.
Pso
S1 was similar to the KPi value 464 
measured (11mM and 16 mM, respectively at 10 ιC). At higher temperatures the KPi 465 
of actin.
Pso
S1 was weakened to 30-40 mM, the KPi app however remained at about 10 466 
mM for the whole temperature range used.  467 
At pH 6.2 the KPi of psoas was 30 % tighter than at pH 7.0 but otherwise showed the 468 
same behavior as temperature was increased (weakening from 15 mM at 10 °C to 32 469 
mM at 40 °C). The KPi app however appears 2-fold weaker at pH 6.2 for psoas with 24 470 
mM and tightens to about 16 mM as temperature is increased.  471 
For actin.
Mass
S1 we observed a different behavior of the apparent phosphate 472 
dissociation constant; while the measured KPi values at pH 7.0 were similar to psoas 473 
across the temperature range used, the KPi app showed distinct temperature 474 
dependence, weakening from 10 to 40 mM with temperature. The KPi values of 475 
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masseter were unaffected by a change in pH to 6.2 and remained similar to psoas at 476 
22 and 35 mM (10 and 20 °C, respectively). The KPi app however lost its temperature 477 
dependence when the pH was lowered to 6.2 and the value remained relatively 478 
unaffected at 10-15 mM for actin.
Mass
S1 throughout the temperature range used. 479 
Relevance to working muscle.  Work by us and others indicated an important role for 480 
Pi in tension generation as conditions that affect actomyosin affinity, would affect, in 481 
proportion, force generation. With the assumption that A.M force-generating states 482 
are in an effective equilibrium with the non-force-generating states at the beginning 483 
of the working stroke, past skinned psoas fiber work suggested that, with increasing 484 
 ?Wŝ ?ƚŚĞĨƌĞĞĞŶĞƌŐǇŽĨƚŚĞƐƚĂƚĞƐƚŚĂƚƉƌĞĐĞĚĞWŝƌĞůĞĂƐĞĚĞĐƌĞĂƐĞĂƐALZdůŶ ?Wŝ ? ?ĨƌŽŵ485 
the slope of the force-ln[Pi] relationship, relative to the free energy of states after Pi 486 
release, leading to progressive depopulation of the force-generating states and thus 487 
reducing tension generation (33). Earlier observations by Tesi et al (54) highlighted 488 
differences between slow and fast myofibrils in tension response to phosphate, with 489 
indications of stronger actomyosin bonds in slow muscle. The combination of low pH 490 
and high Pi was shown to synergistically inhibit velocity of contraction in skinned 491 
fibres (36, 43) adding further support to the notion that in fatigue conditions, the 492 
combined effect of Pi and protons on muscle performance would come about either 493 
by decreasing the force per bridge and/or increasing the number of low-force 494 
bridges. These and other studies indicated that the effect of Pi on its own is 495 
moderate at higher temperatures but in combination with low pH it can substantially 496 
affect muscle power by affecting actomyosin interaction. The present work adds 497 
ŝŵƉŽƌƚĂŶƚŝŶĨŽƌŵĂƚŝŽŶƚŽĞǆƉůĂŝŶŚŽǁWŝ ?ƐŝŶƚĞraction changes the ADP dissociation 498 
constant for AM and ultimately ATP-induced dissociation of AM, thus the speed of 499 
the cross-bridge cycle. 500 
Concluding remarks 501 
The phenomena we studied are at a lower level of component configuration, actin 502 
and myosin S1 in solution. We cannot therefore account for myosin cooperativity 503 
and coordinated responses to load, which could affect the hypothesized limiting 504 
processes.  While experimental data imply such cooperativities (3) emerging 505 
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behaviors are difficult to assess and model, a situation further complicated by the 506 
difficulty of incorporating intra-head actions into models (40). At the macroscopic 507 
level, many studies have examined fatigue effects on mechanical function using 508 
single fibers (most however at non-physiological temperature); there are also 509 
isolated muscle and whole limb investigations (however with no control over 510 
metabolites levels); all these macroscopic studies have theorized about what may be 511 
ŽĐĐƵƌƌŝŶŐĂƚƚŚĞŵŽůĞĐƵůĂƌůĞǀĞů ?&ĞǁĞƌƐƚƵĚŝĞƐŚĂǀĞĂƚƚĞŵƉƚĞĚĂ ‘molecular 512 
explanation ?ŽĨŚŽǁǀĞůŽĐŝƚǇŝƐĂĨĨĞĐƚĞĚŝŶ muscle fatigue (e.g. using in vitro motility 513 
(16)). Ours is the first study to employ solution transient kinetics to study how key 514 
fatigue factors affect the ATP-induced dissociation step of fast and slow S1 from 515 
actin (a critical part of the cycle that affects overall velocity). More information of 516 
the other events in the cycle, and the temperature dependence of these events for 517 
both fiber types, is needed to support future modelling attempts. 518 
It remains to be seen how our findings can be integrated at the higher level 519 
 ‘ďĞŚĂǀŝŽƌ ?ŽĨůĂƌŐĞŵǇŽƐŝŶĞŶƐĞŵďůĞƐŝŶƚĞƌĂĐƚŝŶŐǁŝƚŚĂĐƚŝŶĨŝůĂŵĞŶƚƐ ?ŽƵƚƐŝĚĞŽƌ520 
inside an organized sarcomere. It is expected that in such situations other laws may 521 
apply when the myosin type effect on contractile behavior is further modulated 522 
depending on interactions with intracellular factors and overall muscle action 523 
regulation.  524 
We expect that, given the undisputed phenotypic effect of myosin types as observed 525 
in mammalian physiology, our data provide highly relevant insights in the 526 
mechanochemical coupling factors that distinguish the fiber types. Phosphate 527 
dependence of ATP-induced dissociation is modulated by variations in actin affinity. 528 
Such variations could help modulate the phosphate dependence of force and 529 
velocity, and may explain why phosphate sensitivity appears to be in part 530 
temperature-and muscle type-dependent. 531 
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Figures & Captions 714 
  
  
Figure 1.  ATP-induced dissociation of S1 from actin, for fast (Pso) and slow (Mass) myosin 715 
isoform, at pH 7.0 and 6.2, in a range of temperatures. A. Normalized transients observed 716 
when mixing 0.5 µM pyr-act.PsoS1 with 25 µM ATP in pH 7.0 buffer at different 717 
temperatures (selected transients are shown). The change in fluorescence was fitted to a 718 
single exponential equation (best fits superimposed), giving kobs of 84.8, 136.2, 208.5, 296.9, 719 
and 374.4 s
-1
 for 5, 15, 25, 35 and 43 °C, respectively. The amplitudes of the transients were 720 
relatively stable at 46 % of total fluorescence change, with some loss observed at 721 
temperatures above 30 °C. B. Normalized transients observed when mixing 0.5 µM 722 
pyrAct.MassS1 with 25 µM ATP in pH 7.0 buffer at different temperatures (selected 723 
transients are shown). The change in fluorescence was fitted to a single exponential 724 
equation (best fits superimposed), giving observed rate constants of 26.7, 36.1, 46.7, and 725 
64.9 s
-1
 for 5, 15, 25 and 35 °C, respectively. The amplitudes of the transients were relatively 726 
stable at 40 % of total fluorescence change, with some loss observed at temperatures above 727 
30 °C.C. Arrhenius plot of the kobs/[ATP]= K1k+2 of Pso at pH 7.0 and pH 6.2 (temperature 728 
range 5  ? 43 °C). The linear fits (best fits superimposed) gave slopes of -3.41 ±0.10 and -3.52 729 
±0.09 K for pH 7.0 and 6.2, respectively, from which the activation energies (Ea) were 730 
calculated as 28.3 ± 0.8 and 29.3 ± 0.8 kJ/mol. D. Arrhenius plot of the kobs/[ATP]= K1k+2 of 731 
Mass at pH 7.0 and pH 6.2 (temperature range 5  ? 43 °C). The linear fits (best fits 732 
superimposed) gave slopes of -3.09 ± 0.17 and -2.86 ± 0.14 K for pH 7.0 and 6.2, respectively, 733 
from which the activation energies (Ea) were calculated as 25.7 ± 1.4 and 23.8 ± 1.1 kJ/mol. 734 































































































































Figure 2. Effect of inorganic phosphate on the ATP-induced dissociation of S1 from actin, for 737 
fast (Pso) and slow (Mass) myosin isoform at pH 7.0 and 6.2, in a range of temperatures. A. 738 
Arrhenius plot of the kobs of Psoas at pH 7.0 and pH 6.2 in the presence of 30 mM Pi. The 739 
linear fits (best fits superimposed) gave slopes of -4.54 ±0.15 and -4.71 ±0.20 K for pH 7.0 740 
and 6.2, respectively, from which the activation energies (Ea) were calculated as 37.7 ± 1.2 741 
and 39.2 ± 1.6 kJ/mol. B. Arrhenius plot of the kobs of Masseter at pH 7.0 and pH 6.2 in the 742 
presence of 15 mM Pi. The linear fits (best fits superimposed) gave slopes of -3.59 ± 0.13 and 743 
-3.694 ± 0.08 K for pH 7.0 and 6.2, respectively, from which the activation energies (Ea) were 744 
calculated as 29.9 ± 1.1 and 30.7 ± 0.7 kJ/mol. 745 
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Figure 3. Temperature dependence of the ADP release from pyrAct.MassS1.A. Normalized 749 
fluorescent transients observed when 0.5 µM pyrAct.MassS1 pre-incubated with 75 µM ADP 750 
was mixed with 8 mM ATP at different temperatures between 5 and 30 °C in pH 7.0 buffer 751 
(selected transients are shown). The change in fluorescence was biphasic when observed 752 
over a time scale of 5 sec, however here only the initial fast phase is shown (fits 753 
superimposed). The kobs for the fast phase were 16.2, 26.0, 46.3, 85.0 and 273 s
-1
 for 5, 10, 754 
15, 20 and 30 °C, respectively. B. Arrhenius plot of the kobs of the ADP release rate constant 755 
of Masseter at pH 7.0 and pH 6.2 in the absence and presence of 15 mM Pi. The linear fits 756 
(best fits superimposed) gave slopes of -9.72 ± 0.24 and -10.09 ± 0.33 K for pH 7.0 and 6.2, 757 
and -10.36 ± 0.23 and -9.20 ± 0.31 K for pH 7.0+Pi and pH 6.2 +Pi, respectively. The 758 
activation energies (Ea) were calculated as 75.9 ± 4.1 and 84.7 ± 6.1 kJ/mol for pH 7.0 and 759 
6.2 without phosphate, and 94.4 ± 5.0 and 88.9 ± 3.9 kJ/mol for pH 7.0 and pH 6.2 760 
respectively in the presences of phosphate. 761 
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Figure 4. Temperature dependence of the ADP dissociation constant (KADP) for fast (Pso) and 767 
slow (Mass) A.S1 at pH 7.0. A. Normalized fluorescent transients observed when 0.5 µM 768 
pyrAct.PsoS1 was mixed with 25 µM ATP with various concentrations of ADP present at 20 769 
°C in pH 7.0 buffer. The change in fluorescence was fitted by a single exponential equation 770 
(best fits superimposed). The kobs determined were 87.7, 45.9, 21.4 and 14.5 s
-1
 for zero, 771 
0.25, 1 and 4 mM ADP, respectively, with an amplitude of 30 % of total fluorescence. B. 772 
Fluorescent transients observed when 0.5 µM pyrAct.MassS1 was mixed with 25 µM ATP 773 
with various concentrations of ADP present at 20 °C in pH 7.0 buffer. The change in 774 
fluorescence was fitted to a single exponential equation (best fits superimposed). The kobs 775 
determined were 37.5, 21.7, 9.1 and 2.6 s
-1
 for zero, 25, 100 and 500 µM ADP, respectively, 776 
with an amplitude of 30 % of total fluorescence. C. Plot of the observed rate constants as a 777 
function of [ADP] for Psoas in pH 7.0 buffer at 10, 20 and 30 °C. The data sets were fitted to 778 
a hyperbole to obtain the ADP dissociation constant (KADP) for each temperature: 131 ± 16 779 
µM (10 °C), 140 ± 14 µM (20 °C) and 213 ± 29 µM (30 °C) for the depicted data. Refer to 780 
Table 1 for average values for from measurements in different days. D. Plot of the observed 781 
rate constants as a function of [ADP] for Masseter in pH 7.0 buffer at 10, 20 and 30 °C. The 782 
data sets were fitted to a hyperbole to obtain the ADP dissociation constant (KADP) for each 783 
temperature: 9.6 ± 0.7 µM (10 °C), 31.3 ± 4.0 µM (20 °C) and 62.4 ± 6.1 µM (30 °C) for the 784 
depicted data. Refer to Table 1 for average values from measurements in different days. 785 









































Figure 5.  Effect of phosphate (Pi) on the KAD of fast (Pso) and slow (Mass) A.S1. A. Plot of the 787 
observed rate constants as a function of [ADP] for Psoas in the presence and absence of 788 
added 30 mM Pi (pH 7.0 buffer at 20 °C). The data sets were fitted to a hyperbole to obtain 789 
the ADP dissociation constant (KADP) ± Pi: 175 ± 22 µM (no Pi) and 510 ± 22 µM (with Pi). 790 
Refer to Table 1 for average values for from measurements in different days. B. Plot of the 791 
observed rate constants as a function of [ADP] for Masseter in the presence and absence of 792 
added 15 mM Pi (pH 6.2 buffer at 20 °C). The data sets were fitted to a hyperbole to obtain 793 
the ADP dissociation constant (KADP) ± Pi: 48.4 ± 6.8 µM (no Pi) and 94.5 ± 8.1 µM (with Pi). 794 
Refer to Table 1 for average values for from measurements in different days. C. Plot of the 795 
observed rate constants as a function of [ADP] for Psoas in pH 7.0 buffer in the presence of 796 
added 30 mM Pi at 10, 20 and 30 °C. The data sets were fitted to a hyperbole to obtain the 797 
ADP dissociation constant (KADP) for each temperature: 530 ± 36 µM (10 °C), 510 ± 22 µM (20 798 
°C) and 942 ± 117 µM (30 °C). Refer to Table 1 for average values for from measurements in 799 
different days. D. Plot of the observed rate constants as a function of [ADP] for Masseter in 800 
pH 6.2 buffer in the presence of added 15 mM Pi at 10, 20 and 30 °C. The data sets were 801 
fitted to a hyperbole to obtain the ADP dissociation constant (KADP) for each temperature: 802 
52.2 ± 5.8 µM (10 °C), 94.5 ± 8.1 µM (20 °C) and 175.3 ± 9.7 µM (30 °C). Refer to Table 1 for 803 
average values for from measurements in different days. 804 
 805 
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Figure 6. Phosphate (Pi) dissociation constant for A.M in the absence of ADP (phosphate) at 809 
pH 6.2, for fast (Pso) and slow (Mass) myosin isoform. A. Plot of the observed rate constants 810 
of the ATP-induced dissociation of 0.5 µM pyrAct.S1 by 50 µM ATP as a function of [Pi] for 811 
Psoas (pH 6.2 buffer) at 10 to 40 °C. The data sets were fitted to a hyperbole to obtain the Pi 812 
dissociation constant (KPi) for each temperature: 11.7 ± 1.8 mM (10 °C), 12.7 ± 0.2 mM (20 813 
°C), 15.5 ± 0.7 mM (30 °C) and 22.1 ± 1.2 mM (40 °C). Refer to Table 1 for average values for 814 
from measurements in different days. B. Plot of the observed rate constants of the ATP-815 
induced dissociation of 0.5 µM pyrAct.S1 by 25 µM ATP as a function of [Pi] for Masseter (pH 816 
6.2 buffer) at 10 to 40 °C. The data sets were fitted to a hyperbole to obtain the Pi 817 
dissociation constant (KPi) for each temperature: 17.3 ± 1.1 mM (10 °C), 22.0 ± 1.4 mM (20 818 
°C), 26.1 ± 1.3 mM (30 °C) and 26.7 ± 2.1 mM (40 °C). Refer to Table 1 for average values for 819 
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Table 1. Average values of kinetic parameters describing the  ATP induced 828 
dissociation rate of actin.S1 for psoas and masseter myosin, in pH 7 and 6.2, under 829 




  834 
31 
 
Table 2. Thermodynamics results (EA values) describing the temperature 835 
dependence of the dissociation rate constant for psoas (Pso) and masseter (Mass) 836 
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Abstract   
The muscle types present with variable fatigue tolerance, in part due to the myosin  
isoform expressed. However, the critical steps that define fatigability in vivo of fast 
vs slow myosin isoforms, at the molecular level, are not yet fully understood. We 
examined the modulation of the ATP-induced myosin sub-fragment 1 (S1) 
dissociation  from pyrene-actin by inorganic phosphate (Pi), pH and temperature 
using a specially modified stopped-flow system (HiTech Scientific SF-61DX2) that 
allowed fast kinetics measurements at physiological temperature. We contrasted the 
properties of rabbit psoas (fast) and bovine masseter (slow) myosins (obtained from 
samples collected from New Zealand rabbits and from a licensed abattoir, 
respectively, according to institutional and national ethics permits). To identify ATP 
cycling biochemical intermediates, we assessed ATP binding to a pre-equilibrated 
mixture of actomyosin and variable [ADP],  pH (pH 7 vs pH 6.2) and Pi (zero, 15 or 30 
added mM Pi) in a range of temperatures (5 to 45
o
C). Temperature and pH variations 
had little, if any, effect on ADP affinity (KADP) for fast S1 but for slow S1 KADP was 
weakened with increasing temperature or low pH. In the absence of ADP, affinity for 
phosphate (KPi) was weakened with increasing temperature for fast S1. In the 
presence of ADP, myosin type differences were revealed at the apparent phosphate 
affinity, depending on pH and temperature. Overall, the data point to distinct 
mechanochemical coupling differences between myosin types which could help 
explain the in vivo observed muscle types differences at rest and during fatigue. 
248 words  
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Mammalian striated muscle contraction depends directly on the interaction of the 
motor protein myosin II,  organized in multi-headed filaments, with the filamentous 
tracks of actin, all arranged along with other proteins into sarcomeres, the 
functional units of muscle (23, 38). In essence whole muscle force output 
eventually depends on the number of myosin cross bridges interacting strongly or 
weakly with actin, while the velocity of contraction depends on the rate at which  
myosin detaches from actin at the end of the working stroke (8).  
Peripheral muscle fatigue is manifested by a transient reduction in work or power 
output induced by physical exertion. Depression of muscle power comes as a result 
of force decline and the slowing of contraction velocity and is accompanied by 
biochemical alterations of the intracellular milieu (9, 18). Because the decline in 
force can be accompanied by a relatively larger reduction of energy turnover (i.e. 
tension economy, observed in in situ (19) or isolated intact muscle models (13),  
fatigue could be also viewed as a physiological protective mechanism saving the 
tissue from a potential energetic crisis.  At the organismal level, fatigue is revealed to 
be a complex multifaceted phenomenon, with a large heterogeneity of research 
outcomes (4) depending, among other factors, on the type, duration and intensity of 
muscular activity employed (5, 7), the muscle composition studied (22) and health 
status (25).  Still, recovery of the muscles performance capacity is observed with 
adequate rest, this being a criterion of physiological peripheral fatigue. At the 
muscle cellular level, changes in muscle mechanics during fatigue could be related to 
either reduction of energy substrates (e.g. causing localized ATP minima (27, 28)) 
and /or accumulation of ATP hydrolysis by-products (e.g. (11, 26, 30, 36, 43) ). This is 
because the interaction of myosin with actin (actomyosin) is not only fueled by ATP 
hydrolysis but it is also modulated by ATP hydrolysis by-products (ADP, Pi, H+) and 
other prevailing intracellular conditions (9). Thus, at the myofibrillar level, and for 
the purposes of this work, fatigue is considered in the context of factors influencing 




The coupling of biochemical steps with mechanical events has, however, not been 
fully elucidated (20) while the laws governing how large ensembles of myosins  
integrate within the organized sarcomere (16, 17, 31) are not yet fully defined. 
Investigations ranging from whole body exercise (5, 25), to intact small muscles or 
fibers (48)  to skinned fibers, (10, 11, 15, 26, 30, 37) or myofibrils (43), and isolated 
molecule approaches (14) have provided strong evidence that  the accumulation of 
inorganic phosphate (Pi) and of hydrogen ions can contribute to, if not cause, 
peripheral muscle fatigue. Still, their exact impact, especially at physiological in vivo 
conditions, has attracted much debate (e.g. (47)). This is further complicated by 
muscle type differences (fast vs slow) in energetics, myosin ATPase, and mechanical 
performance (6, 39, 40) , which can be linked to a great degree to inherent 
properties of the myosin II isoform expressed.  
Myosin II exists in multiple isoforms (39) with slow muscles expressing the type 1  
(MyHC-1 also known as ɴ myosin) and fast muscles expressing one or more of the 
type 2 myosins (MyHC-2a, 2b, or 2x).  The study of kinetics of the actomyosin (A.M) 
interaction cycle  identifies clear intermediate steps  (for a review see (3)).  Such 
studies have revealed that slow skeletal myosin heavy chain isoforms (MyHC 1) have 
distinct properties from fast isoforms (MyHC 2s) with regards not only to the ATPase 
activity but also to the rate and equilibrium constants of the various biochemical 
steps of the pathway which are expected to dictate their different mechanical 
properties.  For example, efficiency of actin induced ADP displacement from myosin 
(the ratio of ADP affinity for A.M (KAD) over the ADP affinity for myosin (KD)), and 
strain sensitivity (dependence on external mechanical load) can differ substantially 
between fast and slow myosins (3, 20) , with slow myosins binding ADP tightly and 
releasing it at a slower rate than fast myosins. Thus, it is considered that the ADP 
release is the rate limiting step for the maximum contraction velocity of slow 
muscles (24, 35), at least at the temperatures where fibers or myosin solutions are 
usually studied (10 to 22 °C). 
However, in vivo mammalian muscle temperature ranges from 32 to > 40 °C, while in 
severe fatigue, pH drops and inorganic phosphate (Pi) accumulates (21). A number of 
in vitro fiber studies at higher temperatures, have challenged long held views about 
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the individual role of the key fatigue metabolites on mechanics, e.g. low pH on 
force (less of an effect (29, 36, 48)), high Pi on force (less of an effect, (10, 11, 15, 
26)). More importantly, it appears that a higher temperature is necessary to tease 
out physiological synergies; e.g. in skinned fibers, a synergism of myosin light chain 
phosphorylation with low pH and high [Pi] in slowing contraction velocity and 
repressing power output became evident only in experiments performed at a high 
temperature (29) . Overall, many studies now indicate that temperature 
considerations and a holistic, systems, approach are crucial if one wants to 
realistically link muscle function in vivo to actomyosin interaction molecular events 
studied in vitro.  
The steps that control the detachment of the myosin cross-bridge at the end of the 
working stroke from actin are rapid and are thought to limit the shortening velocity, 
a key parameter of muscle function. Temperature predictions from kinetic studies of 
actomyosin in solution (35), suggest that the rate of ADP release may limit unloaded 
velocity for both isoforms. It can be hypothesized that such an ADP effect could be 
aggravated by the presence of hydrogen ions and inorganic phosphate, as in fatigue. 
Therefore the purpose of this research was to study the fast kinetics of ATP-induced 
dissociation of A.M. with and without ADP using the stopped flow.  We examined the 
interplay of fatigue factors, e.g. low pH and high inorganic phosphate (Pi), with 
myosin type, on ATP-induced dissociation of A.M.  Taking advantage of recent 
methodological advancements we studied, for the first time, the ATP-induced 
dissociation of fast and slow S1 from actin in temperatures ranging from 5 to 45 
o
C to 
reveal critical myosin type and/or temperature dependencies of these processes. 
 
Glossary & abbreviations 
A.M: actomyosin complex  
S1: myosin subfragment 1 
actin.S1: actin bound with S1 
K1 : equilibrium constant for the formation of the complex of AM with ATP (denoted 
as A.M.T),  
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k+2: rate constant of isomerization of A.M.T to A-M.T  which is followed by actin 
dissociation 
kobs: observed rate constant of ATP induced dissociation of myosin from actin   
KADP: affinity for ADP  
KPi: affinity for phosphate  
KADP+Pi: affinity for ADP in the presence of phosphate 
MyHC: myosin heavy chain 

Materials and methods 
Ethics Statement 
Muscle tissue was obtained post-mortem from animals treated as recommended by 
national and local guidelines (UK Animals (Scientific Procedures) Act, 1986).  Fast 
skeletal muscle came from the psoas muscle of New Zealand rabbits and slow 
skeletal muscle from bovine masseter.  
Protein preparation 
Myosin was prepared from the rabbit psoas (for fast MyHC-II) and the bovine 
masseter muscle (for slow MyHC-I) according to Margossian and Lowey (32) , and 
was subsequently digested to subfragment 1 (S1) with chymotrypsin as described by 
Weeds & Taylor (46) .  Actin was prepared from rabbit muscle as described by 
Spudich & Watt (42)  and labelled with pyrene iodoacetamide to give pyrene-
labelled actin as described by Criddle et al (12). Protein stocks of S1 and of pyrene-
labelled actin were stored at 4
o
C and were used for up to 2 weeks.  In the text herein 
reference to actin implies pyrene-labelled actin. 
 
Experimental buffers 
The main buffer contained 20 mM cacodylate (adjusted at pH 7.0 or pH 6.2), 100 
mM KCl, 5 mM MgCl2 and 1 mM NaN3; when phosphate was present in the buffer 
the ionic strength was adjusted accordingly to a final ionic strength of 170 mM. 
Concentrations (whether of proteins or buffer constituents) given in the text and 





Experimental equipment and procedures 
Stopped-flow experiments were performed essentially as described previously (2)  
using a HiTech Scientific SF-61DX2 stopped flow system and 4-5 transients were 
acquired for each ATP transients (Kinetic Studio suite).  The dead time of the 
equipment was 0.002 s.  A wide temperature range (5  45 
o
C) for measurements 
was available because of a new adaptation of the standard stopped flow machine 
(see (45)). Briefly, the drive syringes were held at room temperature (20 °C) while 
loading lines leading into the mixing chamber, the mixing and observation chamber 
were all thermostated at the temperature of the measurement.  Essentially the 
samples were only exposed to the temperature of the measurement for a few 
seconds, thus allowing measurements of proteins under conditions where they are 
not usually stable for long.   
 
The ATP induced dissociation rate of actin.S1, was measured in the stopped-flow by 
mixing a fixed concentration of pyr.actin.S1 complex (end concentration 0.25 ђM) 
with excess ATP and monitoring fluorescence transients from the pyrene-labeled 
actin (excitation at 365 nm, emission through a KV389 nm cut-off filter (Schott, 
Mainz, Germany)).  
 
In a similar process, ADP affinity (KADP) was measured by adding ADP as a 
competitive inhibitor of ATP. In this case 0.5 ђM pyr.actin.S1 was mixed with 25 ђM 
ATP with various concentrations of ADP present with the ATP (from 0 to 1200 ђM).  
 
Phosphate affinity (KPi) was measured exactly as for the ADP affinity except that the 
high concentrations of Pi used meant it was more convenient to have Pi present in 
the buffer in both syringes of the stopped-flow. 
 
ADP affinity in the presence of phosphate (KADP+Pi) was also measured using the 
same approach as for KADP but using buffers containing fixed amounts of inorganic 
phosphate, 30 mM in the case of psoas S1 and 15 mM with masseter S1. The 
different affinities of Pi for the two types of S1 required a different concentration of 
Pi.   
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Experiments were performed at two pH levels, 7 and 6.2 and in a range of 
temperatures. Care was taken to reverse the order of experiments to avoid the 
possibility of a time and order effect either with respects to pH or temperature.  
 
Data Fitting and Interpretation Approach 
In the present study we focused our attention on the ATP induced dissociation of 
actin.S1. This is the step that controls the detachment of the actomyosin cross-
bridge at the end of the working stroke.    
 
 
Scheme 1. Model of ATP-induced dissociation of actin.S1 based on Millar and Geeves 
(33) .  
 
In Scheme 1,  T = ATP; A = actin; M = myosin; I is an inhibitor, competitive with ATP 
for the nucleotide binding site. K1 defines the equilibrium constant for the formation 
of the A.M.T collision complex, which is followed by an almost irreversible 
isomerization of the complex to the ternary complex A-M.T with the rate constant of 
k+2. This is rapidly followed by dissociation of actin from the ternary complex. KI is 
defined as a dissociation constant k+I/k-I.  In the experiments presented here the 
inhibitor was either ADP or inorganic phosphate (Pi). 
 
The reaction described in Scheme 1 was monitored through pyrene fluorescence 
changes which monitor the ATP induced dissociation of actin from the complex 
(fluorescence increases by up to 70 %.), specifically associated with step 2 of Scheme 
1, (see in Results, Fig. 1A). Four to five transients were collected for each ATP 
concentration used then averaged before further analysis.  
 
The averaged transients were fitted with single (eqn1) or, if needed, a double 





©/ -©F? FeFF tkt obs      eqn 1 
or  
¢
©/©/ -©F-©F? FeFeFF tktkt obsobs    eqn 2 
 
Where Ft is the observed fluorescence at time t, Fь is the fluorescence at the end of 
the transient (t=  ь) and ȴF  is the total change of fluorescence observed. The 
observed rate constant (kobs) reflects the ATP induced dissociation rate of actin.S1 
and is linearly dependent on [ATP], at the ATP concentrations used here.  A plot of 
[ATP] vs kobs was used to derive the  values of K1 and k+2 (using Origin v 6.0), as 
defined in scheme 1 and eqn 3. 
  
kobs = K1k+2[ATP] eqn 3 
 
 
The presence of a competitive inhibitor to ATP binding (that does not induce actin.S1 
dissociation) would appear to slow the rate of actin.S1 dissociation.  If inhibitor 
binding is in rapid equilibrium with actin.S1, within the timescale of data acquisition, 
compared to the rate of ATP-induced dissociation of actin.S1 (i.e.  k+AD +[ADP]k-AD >> 
K1k+2[ATP]) , then   
 
kobs = K1k+2[ATP]/(1 + ([ADP]/KI))    eqn 4  
 
Then, plotting kobs as a function of [I] will allow the KI (in scheme 1) to be defined. 
This approach was used to define the value of KI for ADP ( KAD)  and Pi ( KPi).  
 
If both ADP and Pi are present in the same measurement, two scenarios are possible.  
If both compete for the same binding site then the effect of the two inhibitors is 
additive and the effect on kobs can be predicted from the values of KAD and KPi 
measured independently. 
 
 kobs = K1k+2[ATP]/(1 + ([ADP]/KAD) +  ([Pi]/KPi)) eqn 5 
 
where the measured KI at fixed [Pi]    as in KI =    1/KAD  + [Pi]/KPi 
 
If both however bind into the ATP pocket at the same time to create the complex 
A.M.ADP.Pi then the above relationship will not hold and Pi will alter the affinity of 
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A.M for ADP. 
 
The apparent affinity of ADP for actin.S1 (KADP.Pi) was measured for several 
concentrations of Pi and then the affinity of Pi calculated according to the following 
relationship and compared with the  value of KPI. 
KPi app = [Pi]/( KADP+Pi/KADP  1)      eqn 6 
 
 
ADP release rate constant.  Two types of myosins were studied which are known to 
differ in their affinity for nucleotides (3, 41).  The rate constant for the release of 
ADP (k-ADP) is relatively slow and can easily be measured in an ADP displacement 
experiment.  This step is very fast for a fast muscle isoform and too fast to measure 
by current equipment.   Briefly, actin.
Mass
S1 saturated with 75 ђM of ADP (A.M.D 
complex) was mixed with a large excess of ATP (8 mM) in the stopped-flow. Then the 
kobs values, fitted to a single exponential equation (eqn 1) defined the rate constant 
by which ADP is released by the ternary A.M.D complex (k-AD).   
 
The data presented in the figures are the values for the  individual experiment 
displayed, while the data values presented in the table 1 are averaged values for n = 
independent day measurements. 
 
The temperature dependence of the above studied biochemical steps K1k+2,  KAD, KPi 
and KADP Pi data were plotted as the natural logarithm  of the measured parameter  
against the reciprocal of temperature in degrees Kelvin (1/T 
o
K) and fitted with linear 
regression using the Arrhenius (rate constants) or vant Hoff (equilibrium constants)  
equations   
 
ln K1k+2 =ln (A)- Ea/RT   eqn 7 
 
Ln Keq =   ȴS°/R - ȴH°/RT    eqn 8 
 
where Ea stands for activation energy, R is the gas constant, A is a pre-exponential 





Results & Discussion 
ATP induced dissociation rate of actin.S1. When Actin.
Pso
S1  and actin.
Mass
S1  were 
mixed with ATP,  as shown in Figure 1 A and B, the observed stopped-flow transients 
were described by a single exponential for both myosin isoforms (Fig 1A and 1B).  
Keeping a fixed ATP concentration and increasing the temperature allows the best 
estimate of the temperature dependence of the reaction since it minimizes variation 
in ATP concentration between experiments.  Increasing the temperature from 5-43 
°C reduced the total fluorescence signal by ~ 40%  due to collisional quenching but 
the signal change remained relatively constant with an approximately 2-fold increase 
in fluorescence observed in all transients. The transients were therefore normalized 
to illustrate the change in the kobs values.   For psoas (Fig 1 A) and masseter (Fig 1 B) 
temperature increased the kobs value ~3 fold in both cases over the range of 
measurements from 3 to 43 °C.  The figure shows illustrative examples of one set of 
transients.     
Lowering the pH to 6.2 slightly increased the kobs values for both isoforms by about 
20-25 % (and hence the second order rate constant K1k+2, see Table 1).    Increasing 
temperature resulted in an average increase of 3 fold over the temperature range of 
5-35 °C.The amplitudes of the transients at pH 6.2 were again relatively stable and 
similar to pH 7 for 
Pso
S1 at 43 %. For 
Mass
S1 the amplitudes were also stable in pH 6.2 
but showed an overall increase in fluorescence from 40 to 50% of total fluorescence 
signal. 
Effect of temperature: The temperature dependence of the dissociation rate 
constant was examined at pH 7 and then repeated at pH 6.2 (Fig 1C and 1D).   Each 
measurement was repeated 3 times and the average values collated in Table 2. The 
Arrhenius plots of the temperature dependence measurements at pH 7 and 6.2 gave 
well defined straight lines over the temperature range (5  43 
o
C). In the absence of 
phosphate, for psoas the activation energy (Ea) values were very similar at pH 7.0 
and 6.2 as shown in Figure 1 C, 28.3 ± 0.8 and 29.3 ± 0.8 kJ/mol respectively.  For 
masseter, Ea values were on average lower than the ones for fast, being for pH 7.0 
and 6.2, 25.7 ± 1.4 and 23.8 ± 1.1 kJ/mol respectively (Figure 1D). 
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Effect of Pi and pH: When the ATP-induced dissociation measurements were 
repeated in the presence of high phosphate concentrations, of the order that might 
be expected in fatigue, the observed rate constants for the dissociation reaction 
were 2-fold slower for 
Mass
S1 and 2- to 3-fold slower for 
Pso
S1 at both pH levels 
compared to the data in the absence of phosphate.  This is consistent with Pi acting 
as a competitive inhibitor with a Ki of 10  20 mM. It should be noted that while 30 
mM Pi was used for 
Pso
S1, 15 mM Pi was used for 
Mass
S1 experiments.  
The transients of both isoforms had bi-phasic tendencies at the low temperatures (5-
10 °C) at both pHs, but were single exponential at all other temperatures. The origin 
of this additional slow phase, which had a very small amplitude (1-3 %), is not 
known, but possible contamination by ADP was eliminated by control measurements 
in the presence of apyrase.  
The amplitudes of the dissociation reaction were 50 % smaller/reduced in the 




S1, indicating some loss of affinity of 
S1 for actin in the presence of Pi.  However, for psoas the amplitudes increased with 
temperature from 25 to 30 % at pH 7.0 and even more dramatically from 12 to 20 % 
at pH 6.2. This behavior was not observed with 
Mass
S1 masseter.  
Combined effect of temperature, pH and phosphate: the temperature dependence of 
the dissociation rate constant in the presence of phosphate is shown in Figure 2 and 
the activation energies determined for psoas (38 ± 1 kJ/mol) and masseter (30 ± 1 
kJ/mol) were greater than in the absence of Pi, irrespective of the pH used. Thus 
phosphate increased the activation energy of 
Pso
S1 at both pH values by about 10 
kJ/mol, which is a larger increase than observed with masseter, where the increase 
was only about 5 kJ/mol in the presence of phosphate. 
Rate constant of ADP release (k-ADP) was evaluated by an ADP displacement 
experiment, mixing actin.
Mass
S1 saturated with ADP with an excess of ATP. This 
measurement was not possible for 
Psoas




Displacement of ADP from actin.
Mass
S1 by a large excess of ATP was biphasic. The 
transients were well-defined with stable amplitudes of 24 and 6 % for the fast and 
slow phase, respectively (as shown in Figure 3 A).  These amplitudes were similar 
under all conditions explored. The fast phase defines the rate constant at which ADP 
is released and is thought to limit the velocity of shortening of a masseter muscle (2).  
The slower phase is an off pathway event and will not be considered further here. 
The kobs of the ADP release was 85 s
-1
 at 20 °C (pH 7.0) and compares well to 
published results of 94 s
-1
 by Bloemink et al (2). 
 
The reaction was measured over the temperature range of 5 - 30 °C at pH 6.2 and 
7.0, and in the presence of 15 mM Pi.   The kobs values are summarized in the 
Arrhenius plot in Fig 3B. The kobs values increased from 16.2 at 5 °C to 273 s
-1
 at 30 °C 
with similar values at pH 7.0 and pH 6.2 throughout the temperature range used.  
Above 30 °C the reaction was too fast to measure reliably.   Thus the activation 
energy was large with similar values at both pH levels studied. 
 The addition of 15 mM Pi had little effect at pH 7.0. At pH 6.2 however we saw a 30-
50 % increase in kobs in the presence of phosphate and a small change in the 
activation energy.   
 
ADP affinity (KADP)  
The ADP affinity (KADP) for pyr.actin.S1 was measured by the competitive inhibitor 
approach as described in the Methods.  
ADP included in the ATP solution competes with ATP for binding to the pyr.actin.S1 
and slows the kobs value as shown in Fig 4. The ADP affinity was 168 ђM for  PsoS1 and 
31 ђM for MassS1 at 20 °C and pH 7.0, as reported previously22.  This large difference 
in the affinity of actin.S1 for ADP is a major characteristic of a fast vs a slow myosin 
isoform.  As reported previously the ADP affinity for psoas  actin.S1 was relatively 
unaffected by temperature (about 200 ±30 ђM between 10 and 30 °C) while for 
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masseter the effect was much greater, with the affinity becoming weaker by ~6-fold 
from 9.6 ђM at 10 °C to 62.4 at 30 °C, at pH 7.0. 
Effect of pH: A change in pH did not affect the ADP affinity for psoas (Table 1) over 
the temperature range studied (also Figure 4C). Lowering the pH to 6.2 with 
Mass
S1 
resulted in 2-fold weaker KAD values than at pH 7.0 (from 10 to 22 ђM at 10 °C). 
However, this effect of pH was not as pronounced at higher temperatures (only 
weakening by 1.5 fold at 30 °C, see Table 1).  
 
Phosphate affinity (KPi) 
The affinity of Pi for actin.S1 (KPi) was measured but the range of Pi concentrations 
accessible was restricted by the need to maintain a constant ionic strength.  As Pi 
was increased the concentration of KCl in the buffer was decreased and the 
maximum phosphate concentration used was 30 mM.  Figure 6 shows the plots of 
kobs as a function of phosphate concentration for the two myosin isoforms.  These 
show the expected inhibition as [Pi ] is increased with an average KPi value of 15 mM 
at 10 °C decreasing to 41 mM at 40 °C for actin.
Pso
S1 at pH 7.0. Decreasing the pH to 
6.2 did not significantly affect the KPi values for 
Pso
S1 (11 mM at 10 °C, decreasing to 
32 mM at 40 °C, see also Table 1).   
Repeating the measurements with 
Mass
S1 gave a KPi of 22 mM at 10 °C, weakened to 
35 mM at 20 °C (pH 7.0). Lowering the pH to 6.2 resulted in an average KPi value of 
17 mM at 10 °C, weakening to 28 mM at 40 °C. Thus a differential response of slow 
myosin to Pi was observed with temperature, with the slow myosin while starting off 
less sensitive to Pi at 10°C becoming more sensitive to Pi at 40°C. 
 
ADP affinity in the presence of phosphate (KADP+Pi) was evaluated as for the ADP 
affinity but using fixed amounts of inorganic phosphate (30 mM in the case of 
Pso
S1 
and 15 mM with 
Mass
S1). The presence of 30 mM Pi weakened the ADP affinity 
(KADP+Pi) for actin.
Pso
S1 3-4-fold (from about 170 ђM to 890 ђM at 20 °C (pH 7.0)) as 
shown in Figure 5A and Table 1.  Repeating the measurement at different 
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temperatures showed the apparent KADP weakening  from around 500 ђM at 10-20 
°C to 942 ђM at 30 °C (Fig 5C and Table 1).   For masseter the effects of Pi were less 
marked, with the KADP weakening only 1-2-fold across the temperature range at pH 
7.0. Overall, it appears that phosphate competes with ADP binding to fast A.M, but 
has little effect on ADP binding in slow A.M. 
Lowering the pH to 6.2 resulted in a smaller effect of phosphate on the ADP affinity 
for actin. 
Pso
S1, changing only 2-fold from 228 to 514 ђM at 20 °C (compared to the 3 
to 4-fold change seen at pH 7.0). This reduced effect of phosphate was seen across 
the temperature range used. In actin.
 Mass
S1, 15 mM Pi weakened the ADP affinity 2-
fold from 47 to 94 ђM at 20 °C, and a similar 2-fold weakening of the KADP in 
phosphate (KADP+Pi ) was seen at the other temperatures used at pH 6.2. 
Apparent phosphate affinity (KPi app) 
The apparent affinity of phosphate for acto-myosinS1 (KPi app) in the presence of ADP 
was calculated from the ADP affinities measured in the absence (KADP) and presence 
of phosphate (KADP+Pi) as detailed in the methods. At pH 7.0 and low temperature the 
KPi app of actin.
Pso
S1 was similar to the KPi value measured (11mM and 16 mM, 
respectively at 10 ソC). At higher temperatures the KPi of actin.PsoS1 was weakened to 
30-40 mM, the KPi app however remained at about 10 mM for the whole temperature 
range used.  
At pH 6.2 the KPi of psoas was 30 % tighter than at pH 7.0 but otherwise showed the 
same behavior as temperature was increased (weakening from 15 mM at 10 °C to 32 
mM at 40 °C). The KPi app however appears 2-fold weaker at pH 6.2 for psoas with 24 
mM and tightens to about 16 mM as temperature is increased.  
For actin.
Mass
S1 we observed a different behavior of the apparent phosphate affinity; 
while the measured KPi values at pH 7.0 were similar to psoas across the 
temperature range used, the KPi app showed distinct temperature dependence, 
weakening from 10 to 40 mM with temperature. The KPi values of masseter were 
unaffected by a change in pH to 6.2 and remained similar to psoas at 22 and 35 mM 
(10 and 20 °C, respectively). The KPi app however lost its temperature dependence 
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when the pH was lowered to 6.2 and the value remained relatively unaffected at 10-
15 mM for actin.
Mass
S1 throughout the temperature range used. 
Relevance to working muscle.  Work by us and others indicated an important role for 
Pi in tension generation as conditions that affect actomyosin affinity affect, in 
proportion, force generation. With the assumption that A.M force-generating states 
are in an effective equilibrium with the non-force-generating states at the beginning 
of the working stroke, past skinned psoas fiber work suggested that, with increasing 
[Pi] the free energy of the states that precede Pi release decrease as оRT ln[Pi] (from 
the slope of the force-ln[Pi] relationship, relative to the free energy of states after Pi 
release, leading to progressive depopulation of the force-generating states and thus 
reducing tension generation (26). Earlier observations by Tesi et al (44) highlighted 
differences between slow and fast myofibrils in tension response to phosphate, with 
indications of stronger actomyosin bonds in slow muscle. The combination of low pH 
and high Pi was shown to synergistically inhibit velocity of contraction in skinned 
fibres (29, 34) adding further support to the notion that in fatigue conditions, the 
combined effect of Pi and protons on muscle performance would come about either 
by decreasing the force per bridge and/or increasing the number of low-force 
bridges. These and other studies indicated that the effect of Pi on its own is 
moderate at higher temperatures but in combination with low pH it can substantially 
affect muscle power by affecting actomyosin interaction. The present work adds 
important information to explain how Pis interaction changes the ADP affinity for 
AM and ultimately ATP-induced dissociation of AM, thus the speed of the cross-
bridge cycle. 
Concluding remarks 
The phenomena we studied are at a lower level of component configuration, 
solution actin and myosin S1. We cannot there account for myosin cooperativity and 
coordinated responses to load, which could affect the hypothesized limiting 
processes.  While experimental data imply such cooperativities (1) emerging 
behaviors are difficult to assess and model, a situation further complicated by the 
difficulty of incorporating intra-head actions into models (31). It remains to be seen 
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how our findings can be intergraded at the higher level behavior of large myosin 
ensembles interacting with actin filaments, outside or inside an organized 
sarcomere. It is expected that in such situations other laws may apply when the 
myosin type effect on contractile behavior is further modulated depending on 
interactions with intracellular factors and overall muscle action regulation.  
We expect that, given the undisputed phenotypic effect of myosin types as observed 
in mammalian physiology, our data provide highly relevant insights in the 
mechanochemical coupling factors that distinguish the fiber types. Phosphate 
dependence of ATP-induced dissociation is modulated by variations in actin affinity. 
Such variations could help modulate the phosphate dependence of force and 
velocity, and may explain why phosphate sensitivity appears to be in part 
temperature-and muscle type-dependent. 
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Figure 1.  ATP-induced dissociation of S1 from actin, for fast (Pso) and slow (Mass) myosin 
isoform, at pH 7.0 and 6.2, in a range of temperatures. A. Normalized transients observed 
when mixing 0.5 ђM pyr-act.PsoS1 with 25 ђM ATP in pH 7.0 buffer at different 
temperatures (selected transients are shown). The change in fluorescence was fitted to a 
single exponential equation (best fits superimposed), giving kobs of 84.8, 136.2, 208.5, 296.9, 
and 374.4 s
-1
 for 5, 15, 25, 35 and 43 °C, respectively. The amplitudes of the transients were 
relatively stable at 46 % of total fluorescence change, with some loss observed at 
temperatures above 30 °C. B. Normalized transients observed when mixing 0.5 ђM 
pyrAct.MassS1 with 25 ђM ATP in pH 7.0 buffer at different temperatures (selected 
transients are shown). The change in fluorescence was fitted to a single exponential 
equation (best fits superimposed), giving observed rate constants of 26.7, 36.1, 46.7, and 
64.9 s
-1
 for 5, 15, 25 and 35 °C, respectively. The amplitudes of the transients were relatively 
stable at 40 % of total fluorescence change, with some loss observed at temperatures above 
30 °C.C. Arrhenius plot of the kobs/[ATP]= K1k+2 of Pso at pH 7.0 and pH 6.2 (temperature 
range 5  43 °C). The linear fits (best fits superimposed) gave slopes of -3.41 ±0.10 and -3.52 
±0.09 K for pH 7.0 and 6.2, respectively, from which the activation energies (Ea) were 
calculated as 28.3 ± 0.8 and 29.3 ± 0.8 kJ/mol. D. Arrhenius plot of the kobs/[ATP]= K1k+2 of 
Mass at pH 7.0 and pH 6.2 (temperature range 5  43 °C). The linear fits (best fits 
superimposed) gave slopes of -3.09 ± 0.17 and -2.86 ± 0.14 K for pH 7.0 and 6.2, respectively, 
from which the activation energies (Ea) were calculated as 25.7 ± 1.4 and 23.8 ± 1.1 kJ/mol. 













































































































Figure 2. Effect of inorganic phosphate on the ATP-induced dissociation of S1 from actin, for 
fast (Pso) and slow (Mass) myosin isoform at pH 7.0 and 6.2, in a range of temperatures. A. 
Arrhenius plot of the kobs of Psoas at pH 7.0 and pH 6.2 in the presence of 30 mM Pi. The 
linear fits (best fits superimposed) gave slopes of -4.54 ±0.15 and -4.71 ±0.20 K for pH 7.0 
and 6.2, respectively, from which the activation energies (Ea) were calculated as 37.7 ± 1.2 
and 39.2 ± 1.6 kJ/mol. B. Arrhenius plot of the kobs of Masseter at pH 7.0 and pH 6.2 in the 
presence of 15 mM Pi. The linear fits (best fits superimposed) gave slopes of -3.59 ± 0.13 and 
-3.694 ± 0.08 K for pH 7.0 and 6.2, respectively, from which the activation energies (Ea) were 
calculated as 29.9 ± 1.1 and 30.7 ± 0.7 kJ/mol. 
  







































Figure 3. Temperature dependence of the ADP release from pyrAct.MassS1.A. Normalized 
fluorescent transients observed when 0.5 ђM pyrAct.MassS1 pre-incubated with 75 ђM ADP 
was mixed with 8 mM ATP at different temperatures between 5 and 30 °C in pH 7.0 buffer 
(selected transients are shown). The change in fluorescence was biphasic when observed 
over a time scale of 5 sec, however here only the initial fast phase is shown (fits 
superimposed). The kobs for the fast phase were 16.2, 26.0, 46.3, 85.0 and 273 s
-1
 for 5, 10, 
15, 20 and 30 °C, respectively. B. Arrhenius plot of the kobs of the ADP release rate constant 
of Masseter at pH 7.0 and pH 6.2 in the absence and presence of 15 mM Pi. The linear fits 
(best fits superimposed) gave slopes of -9.72 ± 0.24 and -10.09 ± 0.33 K for pH 7.0 and 6.2, 
and -10.36 ± 0.23 and -9.20 ± 0.31 K for pH 7.0+Pi and pH 6.2 +Pi, respectively. The 
activation energies (Ea) were calculated as 75.9 ± 4.1 and 84.7 ± 6.1 kJ/mol for pH 7.0 and 
6.2 without phosphate, and 94.4 ± 5.0 and 88.9 ± 3.9 kJ/mol for pH 7.0 and pH 6.2 






















































Figure 4. Temperature dependence of the ADP affinity (KAD) for fast (Pso) and slow (Mass) 
A.S1 at pH 7.0. A. Normalized fluorescent transients observed when 0.5 ђM pyrAct.PsoS1 
was mixed with 25 ђM ATP with various concentrations of ADP present at 20 °C in pH 7.0 
buffer. The change in fluorescence was fitted by a single exponential equation (best fits 
superimposed). The kobs determined were 87.7, 45.9, 21.4 and 14.5 s
-1
 for zero, 0.25, 1 and 4 
mM ADP, respectively, with an amplitude of 30 % of total fluorescence. B. Fluorescent 
transients observed when 0.5 ђM pyrAct.MassS1 was mixed with 25 ђM ATP with various 
concentrations of ADP present at 20 °C in pH 7.0 buffer. The change in fluorescence was 
fitted to a single exponential equation (best fits superimposed). The kobs determined were 
37.5, 21.7, 9.1 and 2.6 s
-1
 for zero, 25, 100 and 500 ђM ADP, respectively, with an amplitude 
of 30 % of total fluorescence. C. Plot of the observed rate constants as a function of [ADP] 
for Psoas in pH 7.0 buffer at 10, 20 and 30 °C. The data sets were fitted to a hyperbole to 
obtain the ADP affinity (KAD) for each temperature: 131 ± 16 ђM (10 °C), 140 ± 14 ђM (20 °C) 
and 213 ± 29 ђM (30 °C) for the depicted data. Refer to Table 1 for average values for from 
measurements in different days. D. Plot of the observed rate constants as a function of 
[ADP] for Masseter in pH 7.0 buffer at 10, 20 and 30 °C. The data sets were fitted to a 
hyperbole to obtain the ADP affinity (KAD) for each temperature: 9.6 ± 0.7 ђM (10 °C), 31.3 ± 
4.0 ђM (20 °C) and 62.4 ± 6.1 ђM (30 °C) for the depicted data. Refer to Table 1 for average 
values from measurements in different days. 





































Figure 5.  Effect of phosphate (Pi) on the KAD of fast (Pso) and slow (Mass) A.S1. A. Plot of the 
observed rate constants as a function of [ADP] for Psoas in the presence and absence of 
added 30 mM Pi (pH 7.0 buffer at 20 °C). The data sets were fitted to a hyperbole to obtain 
the ADP affinity (KAD) ± Pi: 175 ± 22 ђM (no Pi) and 510 ± 22 ђM (with Pi). Refer to Table 1 for 
average values for from measurements in different days. B. Plot of the observed rate 
constants as a function of [ADP] for Masseter in the presence and absence of added 15 mM 
Pi (pH 6.2 buffer at 20 °C). The data sets were fitted to a hyperbole to obtain the ADP affinity 
(KAD) ± Pi: 48.4 ± 6.8 ђM (no Pi) and 94.5 ± 8.1 ђM (with Pi). Refer to Table 1 for average 
values for from measurements in different days. C. Plot of the observed rate constants as a 
function of [ADP] for Psoas in pH 7.0 buffer in the presence of added 30 mM Pi at 10, 20 and 
30 °C. The data sets were fitted to a hyperbole to obtain the ADP affinity (KAD) for each 
temperature: 530 ± 36 ђM (10 °C), 510 ± 22 ђM (20 °C) and 942 ± 117 ђM (30 °C). Refer to 
Table 1 for average values for from measurements in different days. D. Plot of the observed 
rate constants as a function of [ADP] for Masseter in pH 6.2 buffer in the presence of added 
15 mM Pi at 10, 20 and 30 °C. The data sets were fitted to a hyperbole to obtain the ADP 
affinity (KAD) for each temperature: 52.2 ± 5.8 ђM (10 °C), 94.5 ± 8.1 ђM (20 °C) and 175.3 ± 
9.7 ђM (30 °C). Refer to Table 1 for average values for from measurements in different days. 
 
 
















































































Figure 6. Phosphate (Pi) affinity for A.M in the absence of ADP (phosphate) at pH 6.2, for fast 
(Pso) and slow (Mass) myosin isoform. A. Plot of the observed rate constants of the ATP-
induced dissociation of 0.5 ђM pyrAct.S1 by 50 ђM ATP as a function of [Pi] for Psoas (pH 6.2 
buffer) at 10 to 40 °C. The data sets were fitted to a hyperbole to obtain the Pi affinity (KPi) 
for each temperature: 11.7 ± 1.8 mM (10 °C), 12.7 ± 0.2 mM (20 °C), 15.5 ± 0.7 mM (30 °C) 
and 22.1 ± 1.2 mM (40 °C). Refer to Table 1 for average values for from measurements in 
different days. B. Plot of the observed rate constants of the ATP-induced dissociation of 0.5 
ђM pyrAct.S1 by 25 ђM ATP as a function of [Pi] for Masseter (pH 6.2 buffer) at 10 to 40 °C. 
The data sets were fitted to a hyperbole to obtain the Pi affinity (KPi) for each temperature: 
17.3 ± 1.1 mM (10 °C), 22.0 ± 1.4 mM (20 °C), 26.1 ± 1.3 mM (30 °C) and 26.7 ± 2.1 mM (40 
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Figure 1.  ATP-induced dissociation of S1 from actin, for fast (Pso) and slow (Mass) myosin 
isoform, at pH 7.0 and 6.2, in a range of temperatures. A. Normalized transients observed 
when mixing 0.5 µM pyr-act.PsoS1 with 25 µM ATP in pH 7.0 buffer at different 
temperatures (selected transients are shown). The change in fluorescence was fitted to a 
single exponential equation (best fits superimposed), giving kobs of 84.8, 136.2, 208.5, 296.9, 
and 374.4 s
-1
 for 5, 15, 25, 35 and 43 °C, respectively. The amplitudes of the transients were 
relatively stable at 46 % of total fluorescence change, with some loss observed at 
temperatures above 30 °C. B. Normalized transients observed when mixing 0.5 µM 
pyrAct.MassS1 with 25 µM ATP in pH 7.0 buffer at different temperatures (selected 
transients are shown). The change in fluorescence was fitted to a single exponential 
equation (best fits superimposed), giving observed rate constants of 26.7, 36.1, 46.7, and 
64.9 s
-1
 for 5, 15, 25 and 35 °C, respectively. The amplitudes of the transients were relatively 
stable at 40 % of total fluorescence change, with some loss observed at temperatures above 
30 °C.C. Arrhenius plot of the kobs/[ATP]= K1k+2 of Pso at pH 7.0 and pH 6.2 (temperature 
range 5  ? 43 °C). The linear fits (best fits superimposed) gave slopes of -3.41 ±0.10 and -3.52 
±0.09 K for pH 7.0 and 6.2, respectively, from which the activation energies (Ea) were 
calculated as 28.3 ± 0.8 and 29.3 ± 0.8 kJ/mol. D. Arrhenius plot of the kobs/[ATP]= K1k+2 of 
Mass at pH 7.0 and pH 6.2 (temperature range 5  ? 43 °C). The linear fits (best fits 
superimposed) gave slopes of -3.09 ± 0.17 and -2.86 ± 0.14 K for pH 7.0 and 6.2, respectively, 
from which the activation energies (Ea) were calculated as 25.7 ± 1.4 and 23.8 ± 1.1 kJ/mol. 




























































































































Figure 2. Effect of inorganic phosphate on the ATP-induced dissociation of S1 from actin, for 
fast (Pso) and slow (Mass) myosin isoform at pH 7.0 and 6.2, in a range of temperatures. A. 
Arrhenius plot of the kobs of Psoas at pH 7.0 and pH 6.2 in the presence of 30 mM Pi. The 
linear fits (best fits superimposed) gave slopes of -4.54 ±0.15 and -4.71 ±0.20 K for pH 7.0 
and 6.2, respectively, from which the activation energies (Ea) were calculated as 37.7 ± 1.2 
and 39.2 ± 1.6 kJ/mol. B. Arrhenius plot of the kobs of Masseter at pH 7.0 and pH 6.2 in the 
presence of 15 mM Pi. The linear fits (best fits superimposed) gave slopes of -3.59 ± 0.13 and 
-3.694 ± 0.08 K for pH 7.0 and 6.2, respectively, from which the activation energies (Ea) were 
calculated as 29.9 ± 1.1 and 30.7 ± 0.7 kJ/mol. 
  












































Figure 3. Temperature dependence of the ADP release from pyrAct.MassS1.A. Normalized 
fluorescent transients observed when 0.5 µM pyrAct.MassS1 pre-incubated with 75 µM ADP 
was mixed with 8 mM ATP at different temperatures between 5 and 30 °C in pH 7.0 buffer 
(selected transients are shown). The change in fluorescence was biphasic when observed 
over a time scale of 5 sec, however here only the initial fast phase is shown (fits 
superimposed). The kobs for the fast phase were 16.2, 26.0, 46.3, 85.0 and 273 s
-1
 for 5, 10, 
15, 20 and 30 °C, respectively. B. Arrhenius plot of the kobs of the ADP release rate constant 
of Masseter at pH 7.0 and pH 6.2 in the absence and presence of 15 mM Pi. The linear fits 
(best fits superimposed) gave slopes of -9.72 ± 0.24 and -10.09 ± 0.33 K for pH 7.0 and 6.2, 
and -10.36 ± 0.23 and -9.20 ± 0.31 K for pH 7.0+Pi and pH 6.2 +Pi, respectively. The 
activation energies (Ea) were calculated as 75.9 ± 4.1 and 84.7 ± 6.1 kJ/mol for pH 7.0 and 
6.2 without phosphate, and 94.4 ± 5.0 and 88.9 ± 3.9 kJ/mol for pH 7.0 and pH 6.2 
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Figure 4. Temperature dependence of the ADP dissociation constant (KADP) for fast (Pso) and 
slow (Mass) A.S1 at pH 7.0. A. Normalized fluorescent transients observed when 0.5 µM 
pyrAct.PsoS1 was mixed with 25 µM ATP with various concentrations of ADP present at 20 
°C in pH 7.0 buffer. The change in fluorescence was fitted by a single exponential equation 
(best fits superimposed). The kobs determined were 87.7, 45.9, 21.4 and 14.5 s
-1
 for zero, 
0.25, 1 and 4 mM ADP, respectively, with an amplitude of 30 % of total fluorescence. B. 
Fluorescent transients observed when 0.5 µM pyrAct.MassS1 was mixed with 25 µM ATP 
with various concentrations of ADP present at 20 °C in pH 7.0 buffer. The change in 
fluorescence was fitted to a single exponential equation (best fits superimposed). The kobs 
determined were 37.5, 21.7, 9.1 and 2.6 s
-1
 for zero, 25, 100 and 500 µM ADP, respectively, 
with an amplitude of 30 % of total fluorescence. C. Plot of the observed rate constants as a 
function of [ADP] for Psoas in pH 7.0 buffer at 10, 20 and 30 °C. The data sets were fitted to 
a hyperbole to obtain the ADP dissociation constant (KADP) for each temperature: 131 ± 16 
µM (10 °C), 140 ± 14 µM (20 °C) and 213 ± 29 µM (30 °C) for the depicted data. Refer to 
Table 1 for average values for from measurements in different days. D. Plot of the observed 
rate constants as a function of [ADP] for Masseter in pH 7.0 buffer at 10, 20 and 30 °C. The 
data sets were fitted to a hyperbole to obtain the ADP dissociation constant (KADP) for each 
temperature: 9.6 ± 0.7 µM (10 °C), 31.3 ± 4.0 µM (20 °C) and 62.4 ± 6.1 µM (30 °C) for the 
depicted data. Refer to Table 1 for average values from measurements in different days. 






































 Figure 5.  Effect of phosphate (Pi) on the KAD of fast (Pso) and slow (Mass) A.S1. A. Plot of the 
observed rate constants as a function of [ADP] for Psoas in the presence and absence of 
added 30 mM Pi (pH 7.0 buffer at 20 °C). The data sets were fitted to a hyperbole to obtain 
the ADP dissociation constant (KADP) ± Pi: 175 ± 22 µM (no Pi) and 510 ± 22 µM (with Pi). 
Refer to Table 1 for average values for from measurements in different days. B. Plot of the 
observed rate constants as a function of [ADP] for Masseter in the presence and absence of 
added 15 mM Pi (pH 6.2 buffer at 20 °C). The data sets were fitted to a hyperbole to obtain 
the ADP dissociation constant (KADP) ± Pi: 48.4 ± 6.8 µM (no Pi) and 94.5 ± 8.1 µM (with Pi). 
Refer to Table 1 for average values for from measurements in different days. C. Plot of the 
observed rate constants as a function of [ADP] for Psoas in pH 7.0 buffer in the presence of 
added 30 mM Pi at 10, 20 and 30 °C. The data sets were fitted to a hyperbole to obtain the 
ADP dissociation constant (KADP) for each temperature: 530 ± 36 µM (10 °C), 510 ± 22 µM (20 
°C) and 942 ± 117 µM (30 °C). Refer to Table 1 for average values for from measurements in 
different days. D. Plot of the observed rate constants as a function of [ADP] for Masseter in 
pH 6.2 buffer in the presence of added 15 mM Pi at 10, 20 and 30 °C. The data sets were 
fitted to a hyperbole to obtain the ADP dissociation constant (KADP) for each temperature: 
52.2 ± 5.8 µM (10 °C), 94.5 ± 8.1 µM (20 °C) and 175.3 ± 9.7 µM (30 °C). Refer to Table 1 for 
average values for from measurements in different days. 
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Figure 6. Phosphate (Pi) dissociation constant for A.M in the absence of ADP (phosphate) at 
pH 6.2, for fast (Pso) and slow (Mass) myosin isoform. A. Plot of the observed rate constants 
of the ATP-induced dissociation of 0.5 µM pyrAct.S1 by 50 µM ATP as a function of [Pi] for 
Psoas (pH 6.2 buffer) at 10 to 40 °C. The data sets were fitted to a hyperbole to obtain the Pi 
dissociation constant (KPi) for each temperature: 11.7 ± 1.8 mM (10 °C), 12.7 ± 0.2 mM (20 
°C), 15.5 ± 0.7 mM (30 °C) and 22.1 ± 1.2 mM (40 °C). Refer to Table 1 for average values for 
from measurements in different days. B. Plot of the observed rate constants of the ATP-
induced dissociation of 0.5 µM pyrAct.S1 by 25 µM ATP as a function of [Pi] for Masseter (pH 
6.2 buffer) at 10 to 40 °C. The data sets were fitted to a hyperbole to obtain the Pi 
dissociation constant (KPi) for each temperature: 17.3 ± 1.1 mM (10 °C), 22.0 ± 1.4 mM (20 
°C), 26.1 ± 1.3 mM (30 °C) and 26.7 ± 2.1 mM (40 °C). Refer to Table 1 for average values for 














































Table 1. Average values of kinetic parameters describing the ATP induced dissociation rate of actin.S1 for psoas and masseter myosin, in pH 7 
and 6.2, under different temperatures, in the absence or presence of added phosphate. 
 
 
Psoas S1 Masseter S1 
pH 7.0 6.2 7.0 6.2 
constant KADP KADP+Pi  * KPi calc. KPi KADP KADP+Pi  * KPi calc. KPi KADP KADP+Pi  ** KPi calc. KPi KADP KADP+Pi  ** KPi calc. KPi 






























































































   
31.1 ±1.6 




*30 mM Pi 
**15 mM Pi 
 Table 2. Thermodynamics results (EA values) describing the temperature dependence of the 
dissociation rate constant for psoas (Pso) and masseter (Mass) myosin, under pH 7 and 6.2.  
 
 Pso Mass 
constant ± Pi pH 7.0 pH 6.2 pH 7.0 pH 6.2 
K1k+2    [kJ/mol] - 28.3 ± 0.8 29.3 ± 0.8 25.7 ± 1.4 23.8 ± 1.1 
K1k+2    [kJ/mol] + 37.7 ± 1.2 39.2 ± 1.6 29.9 ± 1.1 30.7 ± 0.7 
k-AD       [kJ/mol] - N/A N/A 75.9 ± 4.1 84.7 ± 6.1 
k-AD       [kJ/mol] + N/A N/A 94.4 ± 5.0 88.9 ± 3.9 
 
